Cargando…
Development of 3D in vitro platform technology to engineer mesenchymal stem cells
This study aims to develop a three-dimensional in vitro culture system to genetically engineer mesenchymal stem cells (MSC) to express bone morphogenic protein-2. We employed nanofabrication technologies borrowed from the spinning industry, such as electrospinning, to mass-produce identical building...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396353/ https://www.ncbi.nlm.nih.gov/pubmed/22802680 http://dx.doi.org/10.2147/IJN.S30434 |
_version_ | 1782238105490685952 |
---|---|
author | Hosseinkhani, Hossein Hong, Po-Da Yu, Dah-Shyong Chen, Yi-Ru Ickowicz, Diana Farber, Ira-Yudovin Domb, Abraham J |
author_facet | Hosseinkhani, Hossein Hong, Po-Da Yu, Dah-Shyong Chen, Yi-Ru Ickowicz, Diana Farber, Ira-Yudovin Domb, Abraham J |
author_sort | Hosseinkhani, Hossein |
collection | PubMed |
description | This study aims to develop a three-dimensional in vitro culture system to genetically engineer mesenchymal stem cells (MSC) to express bone morphogenic protein-2. We employed nanofabrication technologies borrowed from the spinning industry, such as electrospinning, to mass-produce identical building blocks in a variety of shapes and sizes to fabricate electrospun nanofiber sheets comprised of composites of poly (glycolic acid) and collagen. Homogenous nanoparticles of cationic biodegradable natural polymer were formed by simple mixing of an aqueous solution of plasmid DNA encoded bone morphogenic protein-2 with the same volume of cationic polysaccharide, dextran-spermine. Rat bone marrow MSC were cultured on electrospun nanofiber sheets comprised of composites of poly (glycolic acid) and collagen prior to the incorporation of the nanoparticles into the nanofiber sheets. Bone morphogenic protein-2 was significantly detected in MSC cultured on nanofiber sheets incorporated with nanoparticles after 2 days compared with MSC cultured on nanofiber sheets incorporated with naked plasmid DNA. We conclude that the incorporation of nanoparticles into nanofiber sheets is a very promising strategy to genetically engineer MSC and can be used for further applications in regenerative medicine therapy. |
format | Online Article Text |
id | pubmed-3396353 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-33963532012-07-16 Development of 3D in vitro platform technology to engineer mesenchymal stem cells Hosseinkhani, Hossein Hong, Po-Da Yu, Dah-Shyong Chen, Yi-Ru Ickowicz, Diana Farber, Ira-Yudovin Domb, Abraham J Int J Nanomedicine Original Research This study aims to develop a three-dimensional in vitro culture system to genetically engineer mesenchymal stem cells (MSC) to express bone morphogenic protein-2. We employed nanofabrication technologies borrowed from the spinning industry, such as electrospinning, to mass-produce identical building blocks in a variety of shapes and sizes to fabricate electrospun nanofiber sheets comprised of composites of poly (glycolic acid) and collagen. Homogenous nanoparticles of cationic biodegradable natural polymer were formed by simple mixing of an aqueous solution of plasmid DNA encoded bone morphogenic protein-2 with the same volume of cationic polysaccharide, dextran-spermine. Rat bone marrow MSC were cultured on electrospun nanofiber sheets comprised of composites of poly (glycolic acid) and collagen prior to the incorporation of the nanoparticles into the nanofiber sheets. Bone morphogenic protein-2 was significantly detected in MSC cultured on nanofiber sheets incorporated with nanoparticles after 2 days compared with MSC cultured on nanofiber sheets incorporated with naked plasmid DNA. We conclude that the incorporation of nanoparticles into nanofiber sheets is a very promising strategy to genetically engineer MSC and can be used for further applications in regenerative medicine therapy. Dove Medical Press 2012 2012-06-29 /pmc/articles/PMC3396353/ /pubmed/22802680 http://dx.doi.org/10.2147/IJN.S30434 Text en © 2012 Hosseinkhani et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Hosseinkhani, Hossein Hong, Po-Da Yu, Dah-Shyong Chen, Yi-Ru Ickowicz, Diana Farber, Ira-Yudovin Domb, Abraham J Development of 3D in vitro platform technology to engineer mesenchymal stem cells |
title | Development of 3D in vitro platform technology to engineer mesenchymal stem cells |
title_full | Development of 3D in vitro platform technology to engineer mesenchymal stem cells |
title_fullStr | Development of 3D in vitro platform technology to engineer mesenchymal stem cells |
title_full_unstemmed | Development of 3D in vitro platform technology to engineer mesenchymal stem cells |
title_short | Development of 3D in vitro platform technology to engineer mesenchymal stem cells |
title_sort | development of 3d in vitro platform technology to engineer mesenchymal stem cells |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396353/ https://www.ncbi.nlm.nih.gov/pubmed/22802680 http://dx.doi.org/10.2147/IJN.S30434 |
work_keys_str_mv | AT hosseinkhanihossein developmentof3dinvitroplatformtechnologytoengineermesenchymalstemcells AT hongpoda developmentof3dinvitroplatformtechnologytoengineermesenchymalstemcells AT yudahshyong developmentof3dinvitroplatformtechnologytoengineermesenchymalstemcells AT chenyiru developmentof3dinvitroplatformtechnologytoengineermesenchymalstemcells AT ickowiczdiana developmentof3dinvitroplatformtechnologytoengineermesenchymalstemcells AT farberirayudovin developmentof3dinvitroplatformtechnologytoengineermesenchymalstemcells AT dombabrahamj developmentof3dinvitroplatformtechnologytoengineermesenchymalstemcells |